MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

16 Jun 2022 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release dated on 16th June 2022, titled ‘Glenmark becomes the First Pharmaceutical Company to launch Indacaterol + Mometasone Fixed-Dose Combination Drug for Asthma in India’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..